SCR-LIP-000305 · Claim · machine-readable JSON →
In subcutaneous adipose tissue of 11 lipedema patients versus BMI-matched controls, MIF-1 mRNA (fold-change 1.256; p=0.0485) and CD74 mRNA (1.514; p=0.0097) were elevated, with CD74 also overexpressed at the cellular level by immunohistochemistry (7.73 vs 5.18; p=0.0026), while MIF-2 was unchanged and CXCR2 was higher in controls, implicating the MIF-1/CD74 axis in inflammatory macrophage recruitment and polarization in lipedema independent of BMI.
Claim at a glance
- Type
- clinical association
- Knowledge state
- Emerging
- Evidence certainty
- low (GRADE)
- Evidence
- 1 source(s)
- Answers
- 1 question(s)
- Dates
- 2026-05-31 → 2026-05-31
Structured evidence, machine-compiled — not a verdict.
Auto-compiled by the Layer 1 surveillance loop; not yet human-reviewed. anthropic/claude-opus-4.8 · 2026-05-31
Evidence over time
Evidence (1)
- Involvement of the Macrophage Migration Inhibitory Factor (MIF) in Lipedema — Vasella et al. (2023) ✓ verified — consistent · basic science · 2023 · reading confidence: high
“mRNA de MIF-1 significativamente elevado no lipedema vs. controle (media fold-change 1,256; DP 0,303; p=0,0485) e de CD74 (media 1,514; DP 0,397; p=0,0097)”
Small descriptive cross-sectional tissue study (n=11 per group) reporting elevated MIF-1/CD74 expression and macrophage-related inflammatory mechanisms in lipedema adipose tissue, directly addressing inflammation mechanisms; no functional v
Context (PECO)
Answers these questions
Gaps & caveats
Auto-ingested single source; not yet human-reviewed.
Change log
- 2026-05-31 — created · auto-ingested for SQ-LIP-000011